Your browser doesn't support javascript.
loading
Bortezomib washout duration prior to stem cell mobilization in patients with newly diagnosed multiple myeloma.
Luttwak, Efrat; Amit, Odelia; Avivi, Irit; Trestman, Svetlana; Eshel, Rinat; Cohen, Yael C; Ram, Ron.
Affiliation
  • Luttwak E; Bone Marrow Transplantation Unit, Tel Aviv Medical Center, Tel Aviv, Israel.
  • Amit O; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Avivi I; Bone Marrow Transplantation Unit, Tel Aviv Medical Center, Tel Aviv, Israel.
  • Trestman S; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Eshel R; Bone Marrow Transplantation Unit, Tel Aviv Medical Center, Tel Aviv, Israel.
  • Cohen YC; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Ram R; Bone Marrow Transplantation Unit, Tel Aviv Medical Center, Tel Aviv, Israel.
Eur J Haematol ; 105(1): 30-34, 2020 Jul.
Article in En | MEDLINE | ID: mdl-32124519
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bortezomib / Multiple Myeloma / Antineoplastic Agents Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2020 Type: Article Affiliation country: Israel
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bortezomib / Multiple Myeloma / Antineoplastic Agents Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2020 Type: Article Affiliation country: Israel